US 2013/0274273 A1Published application

Inhibiting Transient Receptor Potential Ion Channel TRPA1

AssigneeCubist Pharmaceuticals, Inc.

InventorsChester A. Metcalf, III, Yu Gui Gu, Spencer D. Kimball, Qingy Li, Blaise S. Lippa, Dominic Ryan, Xinyuan Wu, Dong Zou

Life of this patent

Estimating the term…

Abstract

This disclosure describes a novel compounds and pharmaceutical compositions for inhibiting the TRPA1 ion channel and/or medical conditions related to TRPA1, such as pain.

Claims1

Dependent claims

A method for treating or ameliorating pain, comprising intravenously administering to an animal or human an effective amount of a pharmaceutical composition comprising a compound of Formula (Ia), or a pharmaceutically acceptable salt thereof:

Dependencies are inferred from the claim text.

Facts

Application: 13/832,240Filed 15 Mar 2013
Priority: 9 Aug 2011
Published: 17 Oct 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification8 codes

C07D 473/08
With radicals containing only hydrogen and carbon atoms, attached in position 1 or 3: with methyl radicals in positions 1 and 3, e.g. theophylline
A61P 11/06
Drugs for disorders of the respiratory system: antiasthmatics
A61P 25/00
Drugs for disorders of the nervous system
A61P 25/04
Drugs for disorders of the nervous system: centrally acting analgesics, e.g. opioids

Family

Application61/521,705Us provisional application · filed 9 Aug 2011
Application13/571,288Continuation · filed 9 Aug 2012
Application13/832,240Continuation
US 9,193,729 B2Related patent
US 2013/0274273 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…